Clinical Significance of Serum Glutamine Level in Patients with Colorectal Cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical Significance of Serum Glutamine Level in Patients with Colorectal Cancer
Authors
Keywords
-
Journal
Nutrients
Volume 11, Issue 4, Pages 898
Publisher
MDPI AG
Online
2019-04-22
DOI
10.3390/nu11040898
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Morbidity associated with overweight and obesity in health personnel: a 10-year retrospective of hospital-based cohort study in Taiwan
- (2019) Tzu-Lin Yeh et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Targeting Glutamine Metabolism for Cancer Treatment
- (2018) Yeon-Kyung Choi et al. Biomolecules & Therapeutics
- Discriminating gastric cancer and gastric ulcer using human plasma amino acid metabolic profile
- (2018) Fangyu Jing et al. IUBMB LIFE
- Alterations in serum amino-acid profile in the progression of colorectal cancer: associations with systemic inflammation, tumour stage and patient survival
- (2018) Päivi Sirniö et al. BRITISH JOURNAL OF CANCER
- Body Mass Index and Long-Term Outcomes in Patients With Colorectal Cancer
- (2018) Faisal Shahjehan et al. Frontiers in Oncology
- Dietary glutamine, glutamate and mortality: two large prospective studies in US men and women
- (2017) Wenjie Ma et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Amino Acid Profiles of Serum and Urine in Search for Prostate Cancer Biomarkers: a Pilot Study
- (2017) Paweł Dereziński et al. International Journal of Medical Sciences
- Usefulness of Amino Acid Profiling in Ovarian Cancer Screening with Special Emphasis on Their Role in Cancerogenesis
- (2017) Szymon Plewa et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The predictive and prognostic values of serum amino acid levels for clear cell renal cell carcinoma
- (2017) Fan Zhang et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Synthetic lethality of glutaminolysis inhibition, autophagy inactivation and asparagine depletion in colon cancer
- (2017) Jiaqiu Li et al. Oncotarget
- Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
- (2017) et al. JAMA Oncology
- A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics
- (2016) Farshad Farshidfar et al. BRITISH JOURNAL OF CANCER
- Oncogenic PIK3CA mutations reprogram glutamine metabolism in colorectal cancer
- (2016) Yujun Hao et al. Nature Communications
- Pretreatment serum interleukin-1β, interleukin-6, and tumor necrosis factor-αlevels predict the progression of colorectal cancer
- (2016) Pei-Hung Chang et al. Cancer Medicine
- Analysis of Body Mass Index and Mortality in Patients With Colorectal Cancer Using Causal Diagrams
- (2016) Candyce H. Kroenke et al. JAMA Oncology
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Baseline dietary glutamic acid intake and the risk of colorectal cancer: The Rotterdam study
- (2015) Gilson G. Viana Veloso et al. CANCER
- A prognostic analysis of 895 cases of stage III colon cancer in different colon subsites
- (2015) Yan Zhang et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- The effect of glutamine intake on complications of colorectal and colon cancer treatment: A systematic review
- (2015) Maryam Miraghajani et al. Journal of Research in Medical Sciences
- Glutamate dehydrogenase is a novel prognostic marker and predicts metastases in colorectal cancer patients
- (2015) Gaojie Liu et al. Journal of Translational Medicine
- Glutamine at focus: versatile roles in cancer
- (2015) Humberto De Vitto et al. TUMOR BIOLOGY
- Association between Body Mass Index and Prognosis of Colorectal Cancer: A Meta-Analysis of Prospective Cohort Studies
- (2015) Junga Lee et al. PLoS One
- Colorectal Cancer Detection Using Targeted Serum Metabolic Profiling
- (2014) Jiangjiang Zhu et al. JOURNAL OF PROTEOME RESEARCH
- Glutamine and cancer: cell biology, physiology, and clinical opportunities
- (2013) Christopher T. Hensley et al. JOURNAL OF CLINICAL INVESTIGATION
- Metabolomics in cancer biomarker discovery: Current trends and future perspectives
- (2013) Emily G. Armitage et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Metabonomics Identifies Serum Metabolite Markers of Colorectal Cancer
- (2013) Binbin Tan et al. JOURNAL OF PROTEOME RESEARCH
- Serum metabolomics as a novel diagnostic approach for gastrointestinal cancer
- (2011) Atsuki Ikeda et al. BIOMEDICAL CHROMATOGRAPHY
- Metabolomic NMR Fingerprinting to Identify and Predict Survival of Patients with Metastatic Colorectal Cancer
- (2011) I. Bertini et al. CANCER RESEARCH
- Cytokines, Inflammation and Colon Cancer
- (2011) L. Klampfer CURRENT CANCER DRUG TARGETS
- Clinical trial: prophylactic intravenous alanyl-glutamine reduces the severity of gastrointestinal toxicity induced by chemotherapy - a randomized crossover study
- (2009) Y. LI et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer
- (2009) R J DeBerardinis et al. ONCOGENE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More